Clinical studies recruiting near Orange

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · PACT Kidney Care · R1 Therapeutics · NCT06712654 Gen 2 Battrode Wear Study
NA · Baxter Healthcare Corporation · NCT07256951 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · University of California, Irvine (UCI) Health - UC Irvine Me · Eli Lilly and Company · NCT07218380 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · UC Irvine Medical Center, · Joseph Broderick, MD · NCT07227246 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Univ Cali Irvine ALS Neuromuscular · Novartis Pharmaceuticals · NCT05755386 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · UH Minoff Health Center at Chagrin Highlands · Pfizer · NCT07028853 Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Phase N/A · Children's Hospital of Orange County · Arkansas Children's Hospital Research Institute · NCT03827694 Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
NA · University of California, Irvine · University of California, Irvine · NCT06783751 Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or
Phase 3 · Center for Inherited Blood Disorders · CSL Behring · NCT07080905 Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
Phase N/A · Supernus Pharmaceuticals, Inc. · NCT07219927 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · UC Irvine Health/Chao Family Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Children's Hospital of Orange County · National Cancer Institute (NCI) · NCT05099003 Telemedicine to Support Living Kidney Donor Candidates
NA · University of California Irvine Medical Center · University of California, Irvine · NCT07206069 Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Phase 2/Phase 3 · Leiden University Medical Center · NCT05255653 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Mid Florida Hematology and Oncology Center · Pfizer · NCT06758401 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · NRC Research Institute · Bristol-Myers Squibb · NCT06929273 Study of XB010 in Subjects With Solid Tumors
Phase 1 · Exelixis · NCT06545331 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Children's Hospital of Orange County · National Cancer Institute (NCI) · NCT06172296 Tissue Repair Gel in Venous Leg Ulcers in AU/US
Phase 3 · Clincial Research Site 78 · TR Therapeutics · NCT06707103 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Kallyope Inc. · NCT07674654 Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC
Phase 2 · Chao Family Comprehensive Cancer Center, University of Calif · University of California, Irvine · NCT06693323 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · UC Irvine Health - Chao Family Comprehensive Cancer Center · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Phase 1/Phase 2 · Univ Cali Irvine ALS Neuromuscular · Novartis Pharmaceuticals · NCT06704269 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0158 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Children's Hospital of Orange County Main Campus - Orange · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Children's Hospital of Orange County · Children's Oncology Group · NCT06368817 To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Phase 2 · E-Star BioTech, LLC · NCT06343298 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Children's Hospital of Orange County · National Cancer Institute (NCI) · NCT05691478 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Progressive Medical Research · Amgen · NCT07037433

Look up another city

Look up another condition